Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02419755
Title Bortezomib and Vorinostat in Younger Patients With Refractory or Relapsed MLL Rearranged Hematologic Malignancies
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors St. Jude Children's Research Hospital
Age Groups: child
Covered Countries USA

Additional content available in CKB BOOST